New Zealand markets closed

STERIS plc (STE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
213.90+3.69 (+1.76%)
At close: 04:00PM EDT
213.90 0.00 (0.00%)
After hours: 04:45PM EDT

STERIS plc

70 Sir John Rogerson’s Quay
Dublin 2
Dublin D02 R296
Ireland
353 1 232 2000
https://www.steris.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees16,000

Key executives

NameTitlePayExercisedYear born
Mr. Daniel A. CarestioPres, CEO & Director1.63MN/A1973
Mr. Michael J. TokichSr. VP & CFO1.03M8.49M1969
Mr. John Adam ZangerleSr. VP, Gen. Counsel & Sec.800.03kN/A1967
Mr. Walter M. Rosebrough Jr.CEO Emeritus & Sr. Advisor1.16M8.04M1954
Mr. Cary L. MajorsSr. VP of Americas Commercial Operations734.37k1.05M1975
Mr. Andrew XilasSr. VP & GM of Dental1.44MN/A1965
Ms. Karen L. BurtonChief Accounting Officer, VP & ControllerN/AN/A1968
Julie WinterVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Mary Clare FraserVP & Chief HR OfficerN/AN/A1970
Ms. Julia K. MadsenSr. VP of Life SciencesN/AN/A1965
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Corporate governance

STERIS plc’s ISS governance QualityScore as of 31 July 2022 is 4. The pillar scores are Audit: 2; Board: 4; Shareholder rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.